Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dmLT vaccine for ETEC gastroenteritis
NCT02052934Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2014
- Primary completion
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes, Liposomes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dmLT in gastroenteritis, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2014; status: completed.
02
Drugs
dmLT
03
Conditions
gastroenteritis
Beyond the preview
Go deeper on NCT02052934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052934.